Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results

TEL AVIV, Israel, May 17, 2018 /PRNewswire/ — Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the first quarter ended March 31,…